JP2013535220A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013535220A5 JP2013535220A5 JP2013524130A JP2013524130A JP2013535220A5 JP 2013535220 A5 JP2013535220 A5 JP 2013535220A5 JP 2013524130 A JP2013524130 A JP 2013524130A JP 2013524130 A JP2013524130 A JP 2013524130A JP 2013535220 A5 JP2013535220 A5 JP 2013535220A5
- Authority
- JP
- Japan
- Prior art keywords
- formula
- compound
- alkyl
- preparing
- pharmaceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 0 CC(*)C(N(COC(*)=O)C(*)CC(*)c1nc(*)c[s]1)=O Chemical compound CC(*)C(N(COC(*)=O)C(*)CC(*)c1nc(*)c[s]1)=O 0.000 description 4
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US37143310P | 2010-08-06 | 2010-08-06 | |
| US61/371,433 | 2010-08-06 | ||
| PCT/US2011/046797 WO2012019123A1 (en) | 2010-08-06 | 2011-08-05 | Processes for preparing tubulysins |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2013535220A JP2013535220A (ja) | 2013-09-12 |
| JP2013535220A5 true JP2013535220A5 (enExample) | 2014-10-16 |
Family
ID=45559842
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013524130A Ceased JP2013535220A (ja) | 2010-08-06 | 2011-08-05 | ツブリシンを調製するためのプロセス |
Country Status (12)
| Country | Link |
|---|---|
| US (3) | US8889880B2 (enExample) |
| EP (1) | EP2600866A4 (enExample) |
| JP (1) | JP2013535220A (enExample) |
| KR (1) | KR20130096712A (enExample) |
| CN (1) | CN103140227B (enExample) |
| AU (1) | AU2011285532B2 (enExample) |
| BR (1) | BR112013003004A2 (enExample) |
| CA (1) | CA2807511A1 (enExample) |
| EA (1) | EA025471B1 (enExample) |
| MX (1) | MX2013001402A (enExample) |
| SG (1) | SG187728A1 (enExample) |
| WO (1) | WO2012019123A1 (enExample) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5149620B2 (ja) | 2004-07-23 | 2013-02-20 | エンドサイト，インコーポレイテッド | ２価リンカーおよびその結合体 |
| US20100104626A1 (en) | 2007-02-16 | 2010-04-29 | Endocyte, Inc. | Methods and compositions for treating and diagnosing kidney disease |
| NZ580132A (en) | 2007-03-14 | 2012-11-30 | Endocyte Inc | Binding ligand linked drug delivery conjugates of tubulysins to vitamins |
| US9877965B2 (en) | 2007-06-25 | 2018-01-30 | Endocyte, Inc. | Vitamin receptor drug delivery conjugates for treating inflammation |
| CN104383553A (zh) | 2007-06-25 | 2015-03-04 | 恩多塞特公司 | 含有亲水性间隔区接头的共轭物 |
| WO2009055562A1 (en) | 2007-10-25 | 2009-04-30 | Endocyte, Inc. | Tubulysins and processes for preparing |
| MX2013001402A (es) | 2010-08-06 | 2013-08-29 | Endocyte Inc | Proceso para preparar tubulisinas. |
| US10080805B2 (en) | 2012-02-24 | 2018-09-25 | Purdue Research Foundation | Cholecystokinin B receptor targeting for imaging and therapy |
| US20140080175A1 (en) | 2012-03-29 | 2014-03-20 | Endocyte, Inc. | Processes for preparing tubulysin derivatives and conjugates thereof |
| JP2015536323A (ja) | 2012-10-16 | 2015-12-21 | エンドサイト・インコーポレイテッドＥｎｄｏｃｙｔｅ， Ｉｎｃ． | 非天然アミノ酸を含む薬物送達結合体および使用方法 |
| AU2013344778C1 (en) | 2012-11-15 | 2024-06-27 | Endocyte, Inc. | Conjugates for treating diseases caused by PSMA expressing cells |
| US20140249315A1 (en) * | 2013-03-01 | 2014-09-04 | Endocyte, Inc. | Processes for preparing tubulysins |
| ES2843537T3 (es) | 2014-01-28 | 2021-07-19 | Tube Pharmaceuticals Gmbh | Compuestos citotóxicos de tubulisina y conjugados de los mismos |
| SG11201608192SA (en) | 2014-04-11 | 2016-10-28 | Medimmune Llc | Bispecific her2 antibodies |
| US20170304460A1 (en) | 2014-10-01 | 2017-10-26 | Medimmune, Llc | Method of conjugating a polypeptide |
| EA201791896A1 (ru) | 2015-02-25 | 2018-02-28 | Уильям Марш Райс Юниверсити | Дезацетокситубулизин н и его аналоги |
| LT3374398T (lt) | 2015-11-10 | 2020-09-10 | Medimmune, Llc | Asct2 atžvilgiu specifinės surišančios molekulės ir jų panaudojimai |
| US11793880B2 (en) | 2015-12-04 | 2023-10-24 | Seagen Inc. | Conjugates of quaternized tubulysin compounds |
| TWI852735B (zh) | 2015-12-04 | 2024-08-11 | 美商思進公司 | 四級胺化妥布賴森(tubulysin)化合物之結合物 |
| US11414477B2 (en) | 2016-01-27 | 2022-08-16 | Medimmune, Llc | Methods for preparing antibodies with a defined glycosylation pattern |
| CA3020864A1 (en) | 2016-04-15 | 2017-10-19 | Macrogenics, Inc. | Novel b7-h3-binding molecules, antibody drug conjugates thereof and methods of use thereof |
| AR111963A1 (es) | 2017-05-26 | 2019-09-04 | Univ California | Método y moléculas |
| SG11202000499RA (en) | 2017-08-01 | 2020-02-27 | Medimmune Llc | Bcma monoclonal antibody-drug conjugate |
| WO2019108685A1 (en) | 2017-11-29 | 2019-06-06 | William March Rice University | Tubulysin analogues as anticancer agents and payloads for antibody-drug conjugates and methods of treatment therewith |
| CA3193594A1 (en) | 2020-09-11 | 2022-03-17 | Medimmune Limited | Therapeutic b7-h4 binding molecules |
| US11807685B2 (en) | 2021-08-05 | 2023-11-07 | The Uab Research Foundation | Anti-CD47 antibody and uses thereof |
| WO2023083846A1 (en) | 2021-11-10 | 2023-05-19 | Astrazeneca Ab | Antibody molecules and conjugates |
| GB202117928D0 (en) | 2021-12-11 | 2022-01-26 | Cancer Research Tech Ltd | Immunotherapy for cancer |
| AU2023229884A1 (en) | 2022-03-09 | 2024-10-10 | Astrazeneca Ab | BINDING MOLECULES AGAINST FRα |
| IL317733A (en) | 2022-06-27 | 2025-02-01 | Astrazeneca Ab | Combinations involving epidermal growth factor receptor tyrosine kinase inhibitors for cancer treatment |
| JP2026506049A (ja) | 2023-02-16 | 2026-02-20 | アストラゼネカ・アクチエボラーグ | 治療用結合分子を用いた癌の治療のための併用療法 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5627165A (en) | 1990-06-13 | 1997-05-06 | Drug Innovation & Design, Inc. | Phosphorous prodrugs and therapeutic delivery systems using same |
| WO2004005326A2 (de) | 2002-07-09 | 2004-01-15 | Morphochem Aktiengellschaft Fu | Tubulysinkonjugate |
| DK1523493T3 (da) | 2002-07-09 | 2013-12-02 | Alexander Doemling | Nye tubulysinanaloge |
| DE10254439A1 (de) | 2002-11-21 | 2004-06-03 | GESELLSCHAFT FüR BIOTECHNOLOGISCHE FORSCHUNG MBH (GBF) | Tubulysine, Herstellungsverfahren und Tubulysin-Mittel |
| JP5576007B2 (ja) | 2003-01-27 | 2014-08-20 | エンドサイト・インコーポレイテッド | ビタミン受容体結合性薬剤送達結合体 |
| NZ580132A (en) | 2007-03-14 | 2012-11-30 | Endocyte Inc | Binding ligand linked drug delivery conjugates of tubulysins to vitamins |
| DE102009032972A1 (de) | 2009-07-14 | 2011-01-20 | Erbe Elektromedizin Gmbh | Vorrichtung zur Herstellung von Anastomosen |
| WO2011069116A1 (en) | 2009-12-04 | 2011-06-09 | Endocyte, Inc. | Binding ligand linked drug delivery conjugates of tubulysins |
| WO2011106639A1 (en) | 2010-02-25 | 2011-09-01 | Purdue Research Foundation | Psma binding ligand-linker conjugates and methods for using |
| MX2013001402A (es) * | 2010-08-06 | 2013-08-29 | Endocyte Inc | Proceso para preparar tubulisinas. |
-
2011
- 2011-08-05 MX MX2013001402A patent/MX2013001402A/es active IP Right Grant
- 2011-08-05 BR BR112013003004A patent/BR112013003004A2/pt not_active IP Right Cessation
- 2011-08-05 CN CN201180048479.0A patent/CN103140227B/zh not_active Expired - Fee Related
- 2011-08-05 JP JP2013524130A patent/JP2013535220A/ja not_active Ceased
- 2011-08-05 US US13/814,336 patent/US8889880B2/en not_active Expired - Fee Related
- 2011-08-05 CA CA2807511A patent/CA2807511A1/en not_active Abandoned
- 2011-08-05 KR KR1020137004980A patent/KR20130096712A/ko not_active Ceased
- 2011-08-05 WO PCT/US2011/046797 patent/WO2012019123A1/en not_active Ceased
- 2011-08-05 EA EA201390203A patent/EA025471B1/ru not_active IP Right Cessation
- 2011-08-05 SG SG2013008909A patent/SG187728A1/en unknown
- 2011-08-05 AU AU2011285532A patent/AU2011285532B2/en not_active Ceased
- 2011-08-05 EP EP11815381.6A patent/EP2600866A4/en not_active Withdrawn
-
2014
- 2014-10-20 US US14/518,568 patent/US9273091B2/en not_active Expired - Fee Related
-
2016
- 2016-02-26 US US15/054,342 patent/US9499849B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010510976A5 (enExample) | ||
| UA109883C2 (uk) | Спосіб отримання сполук для застосування як інгібіторів sglt2 | |
| EP4282482A3 (en) | Nucleoside phosphoramidate prodrugs | |
| EP3051350A3 (en) | Alcoholic compound and method for producing alcoholic compound | |
| CA2679925A1 (en) | Method for producing high-purity prasugrel hydrochloride | |
| CA2796872A1 (en) | Novel synthesis for thiazolidinedione compounds | |
| EP4230631A3 (en) | Process for making trisubstituted silyloxyethyl triflates | |
| JP2018502077A5 (enExample) | ||
| JP2010519270A5 (enExample) | ||
| MX2009003739A (es) | Derivados de hidrobenzamida como inhibidores de hsp90. | |
| EP3388426A3 (en) | Compounds for protection of cells | |
| JP2015518473A5 (enExample) | ||
| RU2017144050A (ru) | Способ синтеза производных рапамицина | |
| MX2014006992A (es) | Disales de acido malonico y metodo para preparar dihaluros de malonilo. | |
| RU2012128887A (ru) | Способ получения гидрохлорида моксифлоксацина и его промежуточных продуктов | |
| JP2012509265A5 (enExample) | ||
| JP2016523246A5 (enExample) | ||
| JP2013505206A5 (enExample) | ||
| JP2011526896A5 (enExample) | ||
| JP2012503653A5 (enExample) | ||
| JP2008517965A5 (enExample) | ||
| JP2013527149A5 (enExample) | ||
| JP2007519685A5 (enExample) | ||
| CA2554070A1 (en) | Macrolides with antiinflammatory activity | |
| JP2013506705A5 (enExample) |